Veterinary Medicines

BULMECTIN 0,2 % premix pentru furaj medicamentat pentru bovine, ovine, cabaline (care nu sunt destinate consumului uman)

Authorised
  • Abamectin
Download as PDF

Product identification

Medicine name:
BULMECTIN 0,2 % premix pentru furaj medicamentat pentru bovine, ovine, cabaline (care nu sunt destinate consumului uman)
Active substance:
  • Abamectin
Target species:
  • Cattle
  • Sheep
  • Horse (non food-producing)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Abamectin
    2.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Premix for medicated feeding stuff
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        21
        day
    • Sheep
      • Meat and offal
        21
        day
    • Horse (non food-producing)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA02
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Biovet AD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet AD
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 140010
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 24/11/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."